index
MSCI World IMI
Developed-market equities including small caps
These two indices share no constituents. That makes this a portfolio-construction decision rather than a substitution.
index
Developed-market equities including small caps
index
Emerging-market equities
MSCI World IMI is deliberately restricted to developed markets, and MSCI Emerging Markets is deliberately restricted to emerging ones. Combined at index weights they approximate MSCI ACWI IMI's developed-plus-emerging coverage — with the caveat that the emerging index excludes small caps, so the blend is not an exact match.
the portfolio should stay inside developed markets, where the governance, disclosure and settlement regimes are more uniform.
you want dedicated emerging-market exposure and accept higher currency, political and single-country risk in exchange for a different growth and valuation profile.
you hold both and set the emerging weight explicitly, rather than letting it be an accidental residual.
Entity characteristics—not reference-product fees.
| Characteristic | MSCI World IMI | MSCI Emerging Markets |
|---|---|---|
| Exposure | Developed-market equities including small caps | Emerging-market equities |
| Geography | Developed markets worldwide | Emerging markets |
| Market coverage | Large, mid and small cap | Large and mid cap |
| Emerging markets | Not included | Included |
| Small caps | Included | Not included |
| Weighting | Market-cap weighted | Market-cap weighted |
| Index provider | MSCI | MSCI |
“Depends” means the category reflects an investor objective, not universal superiority.
Verified holdings, concentration, country and sector datasets are not currently connected. When available, each dataset will be labelled as official index data or Reference ETF holdings; listing domicile will not be presented as economic revenue exposure.
Because there is no overlap, this is one of the few pairings where holding both genuinely broadens the portfolio. It also means the emerging allocation must be chosen and rebalanced deliberately.
Comparing recent returns and concluding one exposure is obsolete, when the two respond to different currency cycles, commodity cycles and policy regimes.
Historical performance is represented using Grovcap-selected reference exchange-traded products. It is not the official index or spot return series. Fund or ETP returns can differ because of fees, taxes, tracking, cash positions, product structure and other implementation effects. Differences can reflect TER, tracking difference, withholding taxes, sampling, securities lending, cash drag, operating expenses, currency conversion and inception date.
No period is currently comparable across both reference products on a like-for-like currency, basis and reporting-date footing, so no return figures are shown. Grovcap never renders a missing return as 0.00%.
Grovcap does not currently hold a daily net-asset-value time series for these products. Indexed performance charts, annualised volatility, maximum drawdown and return-per-risk therefore remain unavailable rather than being estimated from period returns.
One canonical European exchange-traded product per exposure, chosen by published rules: exact benchmark family, active and published, plain long-only, then accumulating, unhedged, longest usable history and largest established product.
MSCI World IMI reference product
Selected deterministically from 1 eligible product in the Grovcap database — never by commercial arrangement.
MSCI Emerging Markets reference product
Selected deterministically from 24 eligible products in the Grovcap database — never by commercial arrangement.
Related Grovcap guides, rankings and tools to take the next step.
The information provided by Grovcap is for informational and educational purposes only and does not constitute investment, financial, legal, or tax advice. Investing involves risk, including the possible loss of capital. Always conduct your own research or consult a qualified professional before making investment decisions.
Your responses to quizzes, surveys, and other interactive features may be used in aggregated and anonymized form to improve Grovcap and generate investor insights. We do not sell personally identifiable information to third parties. For more information about how we collect, use, and protect your data, please refer to our Privacy Policy.